Gene Mutation Associated With Rare Form Of Diabetes

October 01, 1997

Researchers at the Massachusetts General Hospital (MGH) have discovered that a mutation in a gene that plays a critical role in insulin secretion is associated with a rare, inherited form of diabetes. They also suspect that tiny changes in this gene might be involved in more common forms of type 2 (adult-onset) diabetes. Their report appears in the October issue of Nature Genetics.

"We've identified a new type of diabetes that has a clear origin in a single genetic mutation," says Joel Habener, MD, of the MGH Laboratory of Molecular Endocrinology, who led the study. "Learning more about this gene may lead us to greater insights into common forms of diabetes that are associated with a variety of genetic and environmental factors." Habener also is an investigator with the Howard Hughes Medical Institute.

Diabetes is known to run in families, but common forms of the illness are not inherited in a classic Mendelian fashion -- in which the offspring of affected individuals have a predictable risk of inheriting a disease. Therefore scientists believe that several genes, as well as environmental factors, are involved in determining whether or not an individual will develop diabetes.

However, there are rare forms of type 2 diabetes that do follow a Mendelian pattern of inheritance; each child of an affected individual has a 50 percent chance of becoming diabetic -- indicating that inheritance of a single mutated copy of a gene is sufficient to cause illness. In addition, symptoms of these forms of diabetes first appear when individuals are in their 20s or 30s, compared to common type 2 diabetes, in which symptoms appear in the 40s or 50s. As a result, these forms are called maturity-onset diabetes of the young (MODY).

Three separate genes previously have been associated with forms of MODY; the current paper describes a new form, associated with a gene called insulin promoting factor-1 (ipf-1). This gene is known to be critical in the development of the insulin-secreting beta cells and in stimulating those cells to release insulin in response to rising blood-sugar levels.

Swedish researchers studying ipf-1 discovered that mice without a working copy of the gene never develop a pancreas. Such a phenomenon had never been reported in humans until a member of the MGH team, Doris Stoffers, MD, PhD, first author of the current paper, heard about a baby born without a pancreas in a family with a strong history of diabetes. The child had been under the care of William Clarke, MD, of the University of Virginia Medical School -- a collaborator in the current study -- and was successful treated with insulin therapy. In a study published earlier this year, the MGH-based team reported that this child had identical mutations in both copies of the ipf-1 gene, indicating that the same mutation had been inherited from both parents.

For the current study, the MGH team tested many members of the child's large, extended family and compared that information with the appearance of diabetes over six generations. They found that most of those with diabetes had a single copy of the same mutation seen in the child. The mutation also was seen in several younger members of the family -- including the child's mother -- who had not yet developed diabetes but could in the future. The child's father, who also carries the mutation, had developed diabetes at age 17.

While this particular form of diabetes, called MODY4, is rare, the MGH team believes that further study of the ipf-1 gene may yield information key to understanding common type 2 diabetes. "This gene is critical to insulin secretion, and it is likely that other mutations in this gene will be seen in other families with diabetes," says Habener. "This unusual mutation completely inactivates the gene. But tiny changes in the gene, changes in a single amino acid, might result in a gene that works pretty well but is vulnerable to future damage. That vulnerability could be associated with the obesity-associated diabetes that has been exploding in recent years."

Massachusetts General Hospital

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to